Bb. Tomazic et al., PHYSICOCHEMICAL CHARACTERIZATION OF NATURAL AND BIOPROSTHETIC HEART-VALVE CALCIFIC DEPOSITS - IMPLICATIONS FOR PREVENTION, The Annals of thoracic surgery, 60(2), 1995, pp. 322-327
This investigation was performed to provide a comprehensive physicoche
mical characterization of calcific deposits (CDs) that form on human h
eart valves under various pathological conditions. We examined and cha
racterized CDs associated with aortic stenosis on congenitally bicuspi
d valves (n = 10), degenerative aortic stenosis on valves with previou
sly normal anatomy (n = 10), and rheumatic aortic (n = 10) and mitral
(n = 10) stenosis. Native and deproteinated CDs underwent chemical ana
lysis and structural characterization, whereas deproteinated CDs were
measured for thermodynamic solubility. The CDs in valvular heart disea
se were microcrystalline apatitic products containing substantial amou
nts of sodium, magnesium, carbonate, fluoride, and organic fraction. T
he properties of natural heart valve CDs were compared with those of p
reviously measured CDs that form on or in heart valve biopxostheses. C
ompared with bioprosthetic valve CDs, natural valve CDs have a higher
ratio of calcium to phosphorus, higher crystallinity, and lower solubi
lity. These differences indicate that natural heart valve CDs appear t
o comprise a more mature biomineral. If the formation of mature CDs pr
oceeds through transient stages involving unstable precursors, then th
e main strategy for prevention of calcific deterioration of bioprosthe
tic heart valves would be the development of locally applied long-term
inhibitors that both (1) suppress nucleation and growth of more solub
le precursors and (2) inhibit subsequent augmentation of less soluble
CDs.